Peptide-Enhanced AAV Delivery and AAV-Extended Long-Acting: Advancing Precision in Gene Therapy
26 Sep 2025
Peptide CMC & Process Development
- Integrating peptide ligands into AAV capsids to enhance targeted delivery and cellular uptake, increasing tissue-specific gene expression
- The peptide-modified AAV vectors improve transduction efficiency while potentially reducing off-target effects and required vector doses
- Convergence of peptide engineering and viral vector design to address delivery challenges in next-generation gene therapies.
- Improvement of peptide therapeutic efficacy via AAV vector delivery system
Industry Expert
